货号:A357502
同义名:
Paradol,帕多尔
/ [6]-Paradol; [6]-Gingerone
Paradol是一种有效的肿瘤促进抑制剂,可在小鼠皮肤癌变模型中发挥作用,能够与环氧合酶(COX)-2 活性位点结合,是从生姜等姜科植物中分离并纯化的辛辣酚类物质。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | COX ↓ ↑ | COX-1 ↓ ↑ | COX-2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piroxicam | ✔ | 98% | |||||||||||||||||
| Salicylic acid | ✔ | 98% | |||||||||||||||||
| Phenacetin | ✔ | 98% | |||||||||||||||||
| Etodolac | ✔ | 99% | |||||||||||||||||
| Flunixin meglumine | ✔ | 98% | |||||||||||||||||
| Ibuprofen L-lysine | ✔ | 98% | |||||||||||||||||
| Nabumetone | ✔ | 98% | |||||||||||||||||
| Acemetacin | ✔ | 98% | |||||||||||||||||
| Diflunisal | ✔ | 98% | |||||||||||||||||
| Pranoprofen | ✔ | 98% | |||||||||||||||||
| Ampiroxicam | ✔ | 98% | |||||||||||||||||
| Meloxicam | ✔ | 98% | |||||||||||||||||
| Sulindac | ✔ | 98% | |||||||||||||||||
| Ketoprofen | ✔ | 98% | |||||||||||||||||
| Mefenamic Acid | ✔ | 95% | |||||||||||||||||
| Bromfenac sodium | ✔ | 98% | |||||||||||||||||
| Oxaprozin | ✔ | 99% | |||||||||||||||||
| Aspirin | ✔ | 99% | |||||||||||||||||
| Nepafenac | ✔ | 98% | |||||||||||||||||
| Zaltoprofen | ✔ | 99% | |||||||||||||||||
| Salicin | ✔ | 98% | |||||||||||||||||
| Suprofen | ✔ | 99%+ | |||||||||||||||||
| Xanthohumol | ✔ | 99% | |||||||||||||||||
| Parecoxib | ✔ | 98% | |||||||||||||||||
| Tolfenamic Acid |
+++
COX-2, IC50: 0.2 μM |
98% | |||||||||||||||||
| Etoricoxib | ✔ | 99% | |||||||||||||||||
| Niflumic Acid | ✔ | 98% | |||||||||||||||||
| Valdecoxib |
++++
COX-2, IC50: 5 nM |
99+% | |||||||||||||||||
| Ibuprofen |
+
COX-1, IC50: 13 μM |
+
COX-2, IC50: 370 μM |
98% | ||||||||||||||||
| Indomethacin |
++
COX1, IC50: 0.28 μM |
+
COX-2, IC50: 14 μM |
97% | ||||||||||||||||
| Lornoxicam |
++++
COX-1, IC50: 5 nM |
++++
COX-2, IC50: 8 nM |
98% | ||||||||||||||||
| Meclofenamic acid sodium |
++++
COX-1, IC50: 40 nM |
+++
COX-2, IC50: 50 nM |
99% | ||||||||||||||||
| Asaraldehyde | ✔ | 98% | |||||||||||||||||
| Naproxen |
+
COX-1, IC50: 8.7 μM |
+
COX-2, IC50: 5.2 μM |
98% | ||||||||||||||||
| Diclofenac Sodium Salt |
+++
COX-1, IC50: 60 nM |
+++
COX-2, IC50: 200 nM |
98% | ||||||||||||||||
| NS-398 |
++
COX-2, IC50: 3.8 μM |
95% | |||||||||||||||||
| Amfenac Sodium Hydrate |
++
COX-1, IC50: 250 nM |
+++
COX-2, IC50: 150 nM |
98%+ | ||||||||||||||||
| Nimesulide |
+
COX-2, IC50: 26 μM |
98% | |||||||||||||||||
| Lumiracoxib |
++
COX-1, Ki: 3 μM |
+++
COX-2, Ki: 60 nM |
98% | ||||||||||||||||
| Rutaecarpine | ✔ | 95% | |||||||||||||||||
| Celecoxib |
++++
COX-2, IC50: 40 nM |
98% | |||||||||||||||||
| Carprofen |
++++
canine COX2, IC50: 30 nM |
98% | |||||||||||||||||
| Ketorolac |
++
COX-1 (human), IC50: 1.23 μM |
++
COX-2 (human), IC50: 3.50 μM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Paradols are non-pungent and biotransformed metabolites of shogaols and reduce inflammatory responses as well as oxidative stress as shogaols. Pretreatment with 6-paradol (paradol derivatives) reduced neuroinflammatory responses in LPS-stimulated BV2 microglia by a concentration-dependent manner[3]. [6]-Paradol, a pungent phenolic compound present in certain Zingiberaceae plants, is known to have antimicrobial and analgesic activities. [6]-Paradol can attenuate promotion of skin carcinogenesis and TPA-induced ear edema in female ICR mice, and to induce apoptosis in cultured human promyelocytic leukemia (HL-60) cells[4]. Once-daily administration of 6-shogaol and 6-paradol (5 mg/kg/day, p.o.) to symptomatic EAE (experimental autoimmune encephalomyelitis) mice significantly alleviated clinical signs of the disease along with remyelination and reduced cell accumulation in the white matter of spinal cord[5]. |
| Concentration | Treated Time | Description | References | |
| SW1990 | 0, 20, 40, 80 µM | 0, 24, 48, 72 hours | 6-P significantly suppressed pancreatic cancer cell proliferation and metastasis. | Cancer Cell Int. 2021 Aug 10;21(1):420 |
| MIA PaCa-2 | 0, 20, 40, 80 µM | 0, 24, 48, 72 hours | 6-P significantly suppressed pancreatic cancer cell proliferation and metastasis. | Cancer Cell Int. 2021 Aug 10;21(1):420 |
| SAOS-2 cells | 1 µM | 72 hours | Assessment of proliferative effect, showing paradol significantly decreased the doubling time of SAOS-2 cells | Molecules. 2017 Sep 4;22(9):1467 |
| MG-63 cells | 1 µM | 72 hours | Assessment of proliferative effect, showing paradol significantly decreased the doubling time of MG-63 cells | Molecules. 2017 Sep 4;22(9):1467 |
| MCF-7 cells | 1 µM | 72 hours | Assessment of proliferative effect, showing paradol significantly decreased the doubling time of MCF-7 cells | Molecules. 2017 Sep 4;22(9):1467 |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | Subcutaneous tumor model | Oral | 10 mg/kg | Once daily for 5 weeks | 6-P significantly suppressed tumor growth. | Cancer Cell Int. 2021 Aug 10;21(1):420 |
| Female C57BL/6 mice | Experimental autoimmune encephalomyelitis (EAE) model | Oral | 5 mg/kg/day | Once daily for 13 days (from day 29 to day 42 post immunization) | 6-Paradol significantly alleviated clinical symptoms of EAE mice, reduced demyelination and cell accumulation in the spinal cord, suppressed astrogliosis and microglial activation, and decreased TNF-α expression levels | Biomol Ther (Seoul). 2019 Mar 1;27(2):152-159 |
| Sprague-Dawley rats | Acetic acid-induced ulcerative colitis model | Oral gavage | 50, 100, 200 mg/kg | Once daily for 7 days | To evaluate the protective effect of 6-Paradol against acetic acid-induced ulcerative colitis. Results showed that 6-Paradol significantly improved colonic and serum levels of glutathione (GSH), malondialdehyde (MDA), myeloperoxidase (MPO) activity, serum interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), with the 200 mg/kg dose showing similar protective effects to sulfasalazine (500 mg/kg). | BMC Complement Med Ther. 2021 Jan 13;21(1):28 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.59mL 0.72mL 0.36mL |
17.96mL 3.59mL 1.80mL |
35.92mL 7.18mL 3.59mL |
|
| CAS号 | 27113-22-0 |
| 分子式 | C17H26O3 |
| 分子量 | 278.39 |
| SMILES Code | CCCCCCCC(CCC1=CC=C(O)C(OC)=C1)=O |
| MDL No. | MFCD01736103 |
| 别名 | Paradol,帕多尔 ;[6]-Paradol; [6]-Gingerone; 6-Paradol |
| 运输 | 蓝冰 |
| InChI Key | CZNLTCTYLMYLHL-UHFFFAOYSA-N |
| Pubchem ID | 94378 |
| 存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 |
| 溶解方案 |
DMSO: 135 mg/mL(484.94 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1